TO STUDY THE EFFICACY AND SAFETY OF SITAGLIPTIN IN PATIENTS WITH TYPE-2 DIABETES MELLITUS
Deepak Kumar Patel
openalex +2 more sources
Therapeutic potential of targeting ceramide for early cardiometabolic lipotoxicity in vivo study. [PDF]
Shalaby YM +5 more
europepmc +1 more source
Real-World Data on the Incidence of Macrovascular Complications in Japanese Patients with Type 2 Diabetes: The Sitagliptin Registration Type 2 Diabetes-Juntendo Collaborating Project [PDF]
Hirotoshi Ohmura +7 more
openalex +1 more source
Rapid imaging of pulmonary metastasis from colorectal cancer with a red fluorescence probe targeting puromycin-sensitive aminopeptidase and dipeptidyl peptidase IV. [PDF]
Kobayashi K +5 more
europepmc +1 more source
Green and sustainable LC-APCI-MS/MS method for simultaneous quantification of genotoxic nitrosamines in antidiabetic medication: sitagliptin [PDF]
Sriram Pepakayala +3 more
openalex +1 more source
Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial [PDF]
B Charbonnel +7 more
openalex +1 more source
Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial. [PDF]
Barchetta I +18 more
europepmc +1 more source

